England is expanding wastewater surveillance to detect virus outbreaks early, giving hospitals more time to respond before ...

According to MarketsandMarkets™, the Genomic Biomarkers Market is projected to grow from about USD 29.00 billion in 2025 to ...

PCR-based techniques have transformed how scientists analyze transcripts’ translational applications in cancer and ...

A new test has been developed that can detect ALS, the most common type of motor neurone disease, with nearly 100 per cent accuracy.

Mycoplasma testing is a crucial component of quality control in cell therapy studies. In clinical applications, such as those ...

LeafWorks, a trailblazing botanical genomics and testing company for natural products, today announced the release of its latest innovation: a suite of species-specific DNA tests for six of the most ...

SEBASTOPOL, Calif.--(BUSINESS WIRE)--LeafWorks, a trailblazing botanical genomics and testing company for natural products, today announced the release of its latest innovation: a suite of ...

NEW YORK – With its combination immunoassay and qPCR blood test, Mursla Bio intends to identify liver cancers earlier by detecting microRNA and protein targets within extracellular vesicles. Last week ...

APIS Assay Technologies Ltd. (‘APIS’), a private UK based company specialising in molecular diagnostics, is pleased to ...

LUBBOCK, TEXAS / ACCESS Newswire / February 28, 2025 / MicroGenDX, a leader in clinical molecular diagnostics, is launching Rapid H5, a qPCR test designed to detect H5 avian influenza A variants, such ...

OTTAWA, CANADA, January 30,2025 – Genomadix (genomadix.com), a global leader in point of need precision medicine diagnostics, announced today that they have received a medical device licence (MDL) ...